Lipodox: Cancer Treatment & Imports
February 21, 2012 by staff
Lipodox: Cancer Treatment & Imports, US health authorities said Tuesday they will import a drug to treat ovarian, bone marrow and AIDS-related skin cancer from India in order to ward off a worrying shortage.
“Lipodox will be imported as an alternative to Doxil,” the US Food and Drug Administration said in a statement, noting that a temporary deal has been made with Sun Pharma Global FZE in India to supply US patients with the drug.
“Temporary importation of unapproved foreign drugs is considered in rare cases when there is a shortage of an approved drug that is critical to patients and the shortage cannot be resolved in a timely fashion with FDA-approved drugs.”
Another drug that has been in short supply, methotrexate — needed for treating a variety of cancers including children with leukemia — was approved in preservative-free generic form for maker APP Pharmaceuticals in Illinois and should be available by March, the FDA said.
In the meantime, a shipment of 31,000 vials, or one month’s supply, is being sent right away to hundreds of US hospitals and treatment centers by Hospira, the agency added.
Prescription drug shortages in the United States nearly tripled from 2005 to 2010, according to the Department of Health and Human Services.
Please feel free to send if you have any questions regarding this post , you can contact on
Disclaimer: The views expressed on this site are that of the authors and not necessarily that of U.S.S.POST.